FTC and seven states seek contempt finding against Martin Shkreli over pharmaceutical-industry ban
The FTC and seven states asked a federal judge to hold Martin Shkreli in contempt, alleging he violated his lifetime ban from the pharmaceutical industry.
The Federal Trade Commission and seven states filed a motion in federal court seeking a contempt finding against Martin Shkreli. They allege he traded pharmaceutical stocks and publicly commented on company business despite a court-ordered lifetime industry ban.
The motion seeks sanctions and other measures; Shkreli had not responded to the Guardian's request for comment.